Effect of Clopidogrel Loading and Risk of PCI

Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01339026 ·Status: TERMINATED ·Phase: PHASE4

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

NCT00693069 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

NCT00644657 ·Status: COMPLETED ·Phase: NA

Anticoagulation in Stent Intervention

NCT01141153 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

NCT00404781 ·Status: COMPLETED ·Phase: PHASE4

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)

NCT00910299 ·Status: TERMINATED ·Phase: PHASE2

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

NCT01779401 ·Status: COMPLETED ·Phase: NA

Clopidogrel Resistance and the Possibility of Its Affection

NCT00839345 ·Status: TEMPORARILY_NOT_AVAILABLE

Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

NCT01090336 ·Status: UNKNOWN

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

NCT01582217 ·Status: COMPLETED

Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition

NCT00774475 ·Status: UNKNOWN ·Phase: PHASE3

Platelet Reactivity in Stent Thrombosis Patients

NCT01012544 ·Status: COMPLETED ·Phase: PHASE4

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

NCT01700322 ·Status: COMPLETED ·Phase: PHASE4

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01505790 ·Status: COMPLETED ·Phase: PHASE3

Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI

NCT00517478 ·Status: UNKNOWN

Platelet Function Assessment for Atherothrombotic Patients

NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

NCT02554721 ·Status: COMPLETED ·Phase: PHASE1

Investigation of the Athero-Protective Effects of Clopidogrel

NCT01283282 ·Status: COMPLETED ·Phase: PHASE4

Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents

NCT00589862 ·Status: WITHDRAWN ·Phase: PHASE4

Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity

NCT00638326 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

NCT00661206 ·Status: UNKNOWN ·Phase: PHASE4

Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery

NCT01146301 ·Status: COMPLETED ·Phase: PHASE4

Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation

NCT01094457 ·Status: COMPLETED ·Phase: PHASE4

Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction

NCT00714961 ·Status: COMPLETED ·Phase: PHASE3

Clopidogrel Monotherapy in Patients With High Bleeding Risk

NCT05223335 ·Status: COMPLETED ·Phase: PHASE4